Justin  Leong net worth and biography

Justin Leong Biography and Net Worth

Insider of ResMed
Justin Leong was appointed president of ResMed’s Asian and Latin American markets in June 2020, an extension of his role as president of ResMed’s Asia Growth Markets, held since September 2018, and the region’s senior vice president since May 2016. He is also a director on the board of various ResMed subsidiaries. He joined ResMed in 2013 as vice president of Global Strategy, adding the role of General Manager of Greater China in 2015.

Before joining ResMed, Justin was a director at London-based investment firm HgCapital from 2006 to 2012, responsible for acquisitions and portfolio management, and serving on the board of directors of several European healthcare companies. From 1999 to 2004, he was a management consultant with Bain & Co. in Sydney, Boston and New York, where he advised clients on growth strategies, operational improvement projects, mergers and acquisitions.

Justin holds a Bachelor of Commerce and a Bachelor of Laws from the University of New South Wales, Sydney, and a Master of Business Administration from the Harvard Business School.

What is Justin Leong's net worth?

The estimated net worth of Justin Leong is at least $13.07 million as of November 22nd, 2022. Mr. Leong owns 59,817 shares of ResMed stock worth more than $13,074,202 as of May 19th. This net worth estimate does not reflect any other investments that Mr. Leong may own. Learn More about Justin Leong's net worth.

How do I contact Justin Leong?

The corporate mailing address for Mr. Leong and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected]. Learn More on Justin Leong's contact information.

Has Justin Leong been buying or selling shares of ResMed?

Justin Leong has not been actively trading shares of ResMed over the course of the past ninety days. Most recently, Justin Leong sold 3,777 shares of the business's stock in a transaction on Tuesday, November 22nd. The shares were sold at an average price of $229.50, for a transaction totalling $866,821.50. Following the completion of the sale, the insider now directly owns 59,817 shares of the company's stock, valued at $13,728,001.50. Learn More on Justin Leong's trading history.

Who are ResMed's active insiders?

ResMed's insider roster includes Carol Burt (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.

Are insiders buying or selling shares of ResMed?

In the last twelve months, insiders at the medical equipment provider sold shares 23 times. They sold a total of 70,837 shares worth more than $13,371,821.12. The most recent insider tranaction occured on May, 15th when Director Witte Jan De sold 360 shares worth more than $78,584.40. Insiders at ResMed own 1.2% of the company. Learn More about insider trades at ResMed.

Information on this page was last updated on 5/15/2024.

Justin Leong Insider Trading History at ResMed

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2022Sell3,777$229.50$866,821.5059,817View SEC Filing Icon  
11/5/2020Sell7,740$211.36$1,635,926.4033,126View SEC Filing Icon  
See Full Table

Justin Leong Buying and Selling Activity at ResMed

This chart shows Justin Leong's buying and selling at ResMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ResMed Company Overview

ResMed logo
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $218.57
Low: $217.53
High: $220.04

50 Day Range

MA: $197.71
Low: $173.86
High: $220.63

2 Week Range

Now: $218.57
Low: $132.24
High: $229.97


450,500 shs

Average Volume

1,039,724 shs

Market Capitalization

$32.11 billion

P/E Ratio


Dividend Yield